Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-06

Clinical Trial Update: Novel Calcium Channel Modulators in RLS and Variants: Efficacy & Safety [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating investigational calcium channel modulators for efficacy and safety in restless legs syndrome (including its variants). Recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Investigational calcium channel modulator

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Restless Leg Syndrome (RLS), Variant Restless Legs Syndrome | Phase 1 | Status: RECRUITING